TY - JOUR
T1 - Use of post-acute care services and readmissions after left ventricular assist device implantation in privately insured patients
AU - Dunlay, Shannon M.
AU - Haas, Lindsey R.
AU - Herrin, Jeph
AU - Schilz, Stephanie R.
AU - Stulak, John M.
AU - Kushwaha, Sudhir S.
AU - Shah, Nilay D.
N1 - Funding Information:
Funding: Dr Dunlay is supported by a National Institutes of Health Career Development Award (K23 HL116643).
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Background Very little is known about health care resource utilization, including post-acute care use and hospital readmissions, after left ventricular assist device (LVAD) implantation. Methods and Results Administrative claims from a database of multiple United States health plans were used to identify patients that received an LVAD (ICD-9 code 37.66) and survived to hospital discharge from January 1-2006, through September 30-2013. Post-acute care use was defined as a skilled nursing facility or rehabilitation stay within 90 days after hospital discharge. Patients were censored at heart transplantation or end of coverage through December 31-2013. Of 583 patients (mean age 55 years, 77% male), 223 (38.3%) used post-acute care services, more commonly in patients with diabetes, who required hemodialysis, and who had LVADs implanted at hospitals in more populated areas, with more beds, and in the northeast region (P <.05 for each). The most common reasons for readmission were device complications, heart failure, and arrhythmia. Readmission risk was higher in patients who had diabetes, peripheral vascular disease, and longer hospital length of stay, but it did not differ by post-acute care use. Conclusions Use of post-acute care services varies based on hospital characteristics. We found no association between post-acute care use and readmission risk after LVAD implantation.
AB - Background Very little is known about health care resource utilization, including post-acute care use and hospital readmissions, after left ventricular assist device (LVAD) implantation. Methods and Results Administrative claims from a database of multiple United States health plans were used to identify patients that received an LVAD (ICD-9 code 37.66) and survived to hospital discharge from January 1-2006, through September 30-2013. Post-acute care use was defined as a skilled nursing facility or rehabilitation stay within 90 days after hospital discharge. Patients were censored at heart transplantation or end of coverage through December 31-2013. Of 583 patients (mean age 55 years, 77% male), 223 (38.3%) used post-acute care services, more commonly in patients with diabetes, who required hemodialysis, and who had LVADs implanted at hospitals in more populated areas, with more beds, and in the northeast region (P <.05 for each). The most common reasons for readmission were device complications, heart failure, and arrhythmia. Readmission risk was higher in patients who had diabetes, peripheral vascular disease, and longer hospital length of stay, but it did not differ by post-acute care use. Conclusions Use of post-acute care services varies based on hospital characteristics. We found no association between post-acute care use and readmission risk after LVAD implantation.
KW - Left ventricular assist device
KW - post-acute care
KW - readmission
UR - http://www.scopus.com/inward/record.url?scp=84942830298&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942830298&partnerID=8YFLogxK
U2 - 10.1016/j.cardfail.2015.06.012
DO - 10.1016/j.cardfail.2015.06.012
M3 - Article
C2 - 26093335
AN - SCOPUS:84942830298
SN - 1071-9164
VL - 21
SP - 816
EP - 823
JO - Journal of Cardiac Failure
JF - Journal of Cardiac Failure
IS - 10
ER -